Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.44 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.42 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7750270 | 1.00 | CA2 (0.50) | CA2MAPK1GRIK1GRIK2GPR84 | |
| SCHEMBL28659870 | 1.00 | CA2 (0.50) | CA2MAPK1GRIK1GRIK2GPR84 | |
| SCHEMBL6580215 | 1.00 | CA2 (0.50) | CA2MAPK1GRIK1GRIK2GPR84 | |
| SCHEMBL27590054 | 1.00 | CA2 (0.50) | CA2MAPK1GRIK1GRIK2GPR84 | |
| SCHEMBL9248535 | 0.98 | CA2 (0.52) | CA2MAPK1GRIK1GRIK2GPR84 | |
| SCHEMBL76197 | 0.91 | CA2 (0.48) | CA2MAPK1GRIK1GRIK2GPR84 | |
| SCHEMBL8320113 | 0.91 | CA2 (0.48) | CA2MAPK1GRIK1GRIK2GPR84 | |
| SCHEMBL77006 | 0.91 | CA2 (0.48) | CA2MAPK1GRIK1GRIK2GPR84 | |
| SCHEMBL8374553 | 0.91 | CA2 (0.48) | CA2MAPK1GRIK1GRIK2GPR84 | |
| SCHEMBL10964155 | 0.91 | CA2 (0.48) | CA2MAPK1GRIK1GRIK2GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114045145-B | Adhesive composition | 尤尼吉可株式会社 | 2024-01-23 | — | — | CN | disclosed |
| CN-114045145-A | Adhesive composition | 尤尼吉可株式会社 | 2022-02-15 | — | — | CN | disclosed |
| CN-112969757-A | Resin composition | 尤尼吉可株式会社 | 2021-06-15 | — | — | CN | disclosed |
| EP-1285652-B1 | Novel fatty acid analogues for the treatment of hypertension | THIA MEDICA AS (NO) | 2006-08-16 | — | — | EP | disclosed |
| EP-1284139-B1 | Novel fatty acid analogues for the treatment of fatty liver | THIA MEDICA AS (NO) | 2006-08-02 | — | — | EP | disclosed |
| CN-1244323-C | Novel fatty acid analogues for the treatment of primary and secondary restenosis | THIA MEDICA AS (NO) | 2006-03-08 | — | — | CN | disclosed |
| EP-1075260-B1 | NOVEL FATTY ACID ANALOGUES FOR THE TREATMENT OF SECONDARY RESTENOSIS | THIA MEDICA AS (NO) | 2005-10-19 | — | — | EP | disclosed |
| EP-1075258-B1 | NOVEL FATTY ANALOGUES FOR THE TREATMENT OF OBESITY | THIA MEDICA AS (NO) | 2003-08-20 | — | — | EP | disclosed |
| EP-1075259-B1 | NOVEL FATTY ANALOGUES FOR THE TREATMENT OF DIABETES | THIA MEDICA AS (NO) | 2003-07-23 | — | — | EP | disclosed |
| CN-1300211-A | Novel fatty analogues for the treatment of premary and secondary restenosis | THIA MEDICA AS (NO) | 2001-06-20 | — | — | CN | disclosed |
| EP-0401193-B1 | Rubber compositions having improved processability | MONSANTO EUROPE SA (BE) | 1996-09-18 | — | — | EP | disclosed |
| US-5023289-A | Alkylthioalkanoic acid flow control agent | MONSANTO EUROPE, S.A. (BE) | 1991-06-11 | — | — | US | disclosed |
| EP-0401193-A1 | Rubber compositions having improved processability | MONSANTO EUROPE S.A./N.V. (BE) | 1990-12-05 | — | — | EP | disclosed |